The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Open accessAbstract
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected biologically through some deleterious effects of anticancer treatment on CV health. Anticancer therapies can cause a wide spectrum of short- and long-term cardiotoxic effects. An explosion of novel cancer therapies has revolutionised this field and dramatically altered cancer prognosis. Nevertheless, these new therapies have introduced unexpected CV complications beyond heart failure. Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment. This ESMO consensus article proposes to define CV toxicities related to cancer or its therapies and provide guidance regarding prevention, screening, monitoring and treatment of CV toxicity. The majority of anticancer therapies are associated with some CV toxicity, ranging from asymptomatic and transient to more clinically significant and long-lasting cardiac events. It is critical however, that concerns about potential CV damage resulting from anticancer therapies should be weighed against the potential benefits of cancer therapy, including benefits in overall survival. CV disease in patients with cancer is complex and treatment needs to be individualised. The scope of cardio-oncology is wide and includes prevention, detection, monitoring and treatment of CV toxicity related to cancer therapy, and also ensuring the safe development of future novel cancer treatments that minimise the impact on CV health. It is anticipated that the management strategies discussed herein will be suitable for the majority of patients. Nonetheless, the clinical judgment of physicians remains extremely important; hence, when using these best clinical practices to inform treatment options and decisions, practitioners should also consider the individual circumstances of their patients on a case-by-case basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the cumulative cisplatin dose, peak drug exposure, young age at treatment, co-administration of other ototoxic drugs and others are well-defined risk factors for more severe auditory damage 167,168,169 .”
From Osteosarcoma (2022) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citation2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Self-citationStone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945
Cited by
Sorted by citations
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,457
Self-citationTargeting HER2-positive breast cancer: advances and future directions
Swain, S. M., Shastry, M., & Hamilton, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00579-0 · Cited by 1,160
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Loibl, S., André, F., Bachelot, T., Barrios, C. H., Bergh, J. C. S., Burstein, H. J., Cardoso, M. J., Carey, L., Dawood, S. S., Mastro, L. D., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2023.11.016 · Cited by 1,135
Self-citationBeird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Herrmann, J., Lenihan, D. J., Armenian, S. H., Barac, A., Blaes, A. H., Cardinale, D. M., Carver, J. R., Dent, S. F., Ky, B., Lyon, A. R., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab674 · Cited by 699
Self-citationSunder, S. S., Sharma, U. C., & Pokharel, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01469-6 · Cited by 572
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 541
Self-citationLustberg, M. B., Kuderer, N. M., Desai, A. P., Bergerot, C. D., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 344
Management of common clinical problems experienced by survivors of cancer
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00242-2 · Cited by 326
Alexandre, J., Cautela, J., Éderhy, S., Damaj, G. L., Salem, J., Barlési, F., Farnault, L., Charbonnier, A., Mirabel, M., Champiat, S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018403 · Cited by 303
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Tomuleasa, C., Tigu, A.-B., Munteanu, R. A., Moldovan, C. S., Kegyes, D., Onaciu, A., Gulei, D., Ghiaur, G., Einsele, H., & Croce, C. M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01899-w · Cited by 307
Shi, S., Chen, Y., Luo, Z., Nie, G., & Dai, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01077-5 · Cited by 251
Anthracycline Cardiotoxicity in Adult Cancer Patients
Camilli, M., Cipolla, C. M., Dent, S. F., Minotti, G., & Cardinale, D. M. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.016 · Cited by 250
Self-citationBergom, C. R., Bradley, J. A., Ng, A. K., Samson, P. P., Robinson, C. G., Lopez‐Mattei, J., & Mitchell, J. D. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.06.007 · Cited by 240
Self-citationCardiovascular Manifestations From Therapeutic Radiation
Mitchell, J. D., Cehic, D., Morgia, M., Bergom, C. R., Toohey, J. M., Guerrero, P. A., Ferencik, M., Kikuchi, R., Carver, J. R., Zaha, V. G., et al. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.06.003 · Cited by 226
Self-citationThe Role of Biomarkers in Cardio-Oncology
Ananthan, K., & Lyon, A. R. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10042-3 · Cited by 190
Self-citationESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
de Azambuja, E., Trapani, D., Loibl, S., Delaloge, S., Senkus, E., Criscitiello, C., Poortmans, P. M., Gnant, M., Cosimo, S. D., Cortés, J., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000793 · Cited by 175
Self-citationDempsey, N. G., Rosenthal, A., Dabas, N., Kropotova, Y., Lippman, M. E., & Bishopric, N. H. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06280-x · Cited by 171
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
Beavers, C. J., Rodgers, J. E., Bagnola, A. J., Beckie, T. M., Campia, U., Palo, K. E. D., Okwuosa, T. M., Przespolewski, E. R., & Sj, D. (2022) · Circulation · doi:10.1161/cir.0000000000001056 · Cited by 170
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity
Omland, T., Heck, S. L., & Gulati, G. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.101 · Cited by 172
Okwuosa, T. M., Morgans, A. K., Rhee, J., Reding, K. W., Maliski, S. L., Plana, J.-C., Volgman, A. S., Moseley, K. F., Porter, C., & Ismail-Khan, R. R. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000082 · Cited by 150
Self-citationStrain Imaging in Cardio-Oncology
Liu, J. E., Barac, A., Thavendiranathan, P., & Scherrer‐Crosbie, M. (2020) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.10.011 · Cited by 147
Self-citationFradley, M. G., Beckie, T. M., Brown, S.-A. N., Cheng, R. K.-H., Dent, S. F., Nohria, A., Patton, K. K., Singh, J. P., & Olshansky, B. (2021) · Circulation · doi:10.1161/cir.0000000000000986 · Cited by 152
Self-citationDrapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
Advances in Multimodality Imaging in Cardio-Oncology
Baldassarre, L. A., Ganatra, S., Lopez‐Mattei, J., Yang, E. H., Zaha, V. G., Wong, T. C., Ayoub, C., DeCara, J. M., Dent, S. F., Deswal, A. M., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.743 · Cited by 142
Self-citationThe Cancer Patient and Cardiology
Zamorano, J. L., Gottfridsson, C., Asteggiano, R., Atar, D., Badimón, L., Bax, J. J., Cardinale, D. M., Cardone, A., Feijen, E. A. M., Ferdinandy, P., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1985 · Cited by 137
Self-citationHypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
van Dorst, D. C. H., Dobbin, S. J. H., Neves, K. B., Herrmann, J., Herrmann, S. M., Versmissen, J., Mathijssen, R. H. J., Danser, A. H. J., & Lang, N. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318051 · Cited by 136
Self-citationCardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
Negishi, T., Thavendiranathan, P., Pěnička, M., Lemieux, J., Murbræch, K., Miyazaki, S., Shirazi, M., Santoro, C., Cho, G., Popescu, B. A., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.10.010 · Cited by 129
Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy
Chen, Y., Shi, S., & Dai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113903 · Cited by 125
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies
Georgiopoulos, G. A., Makris, N., Laina, A., Theodorakakou, F., Briasoulis, Α., Trougakos, I. P., Dimopoulos, M. A., Kastritis, E., & Stamatelopoulos, K. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.005 · Cited by 128
Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Bloom, M. W., Vo, J. B., Rodgers, J. E., FERRARI, A. M., Nohria, A., Deswal, A. M., Cheng, R. K.-H., Kittleson, M. M., Upshaw, J. N., Palaskas, N. L., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.08.045 · Cited by 128
Self-citationAvula, V. R., Sharma, G. V., Kosiborod, M., Vaduganathan, M., Neilan, T. G., López‐Fernández, T., Dent, S. F., Baldassarre, L. A., Scherrer‐Crosbie, M., Barac, A., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.08.026 · Cited by 113
Self-citationDitsch, N., Kolberg‐Liedtke, C., Friedrich, M., Jackisch, C., Albert, U., Banys‐Paluchowski, M., Bauerfeind, I., Blohmer, J., Budach, W., Dall, P., et al. (2021) · Breast Care · doi:10.1159/000516419 · Cited by 105
Diretriz Brasileira de Cardio-oncologia – 2020
Hajjar, L. A., Costa, I. B. S. D. S., Lopes, M. A. C. Q., Hoff, P. M., Estevez-Diz, M. D. P., Fonseca, S. M. R., Bittar, C. S., dos Santos, M. H. H., Rizk, S. I., Almeida, D. R., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201006 · Cited by 114
Global Longitudinal Strain in Cardio-Oncology: A Review
Sławiński, G., Hawryszko, M., Liżewska-Springer, A., Nabiałek-Trojanowska, I., & Lewicka, E. (2023) · Cancers · doi:10.3390/cancers15030986 · Cited by 97
Sobczuk, P., Czerwińska, M., Kleibert, M., & Cudnoch‐Jędrzejewska, A. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09977-1 · Cited by 95
Cardiotoxic effects of angiogenesis inhibitors
Dobbin, S. J. H., Petrie, M. C., Myles, R. C., Touyz, R. M., & Lang, N. N. (2021) · Clinical Science · doi:10.1042/cs20200305 · Cited by 98
Dobson, R., Ghosh, A. K., Ky, B., Marwick, T. H., Stout, M., Harkness, A., Steeds, R. P., Robinson, S., Oxborough, D., Adlam, D., et al. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.01.011 · Cited by 93
Self-citationFabiani, I., Aimo, A., Grigoratos, C., Castiglione, V., Gentile, F., Saccaro, L. F., Arzilli, C., Cardinale, D. M., Passino, C., & Emdin, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10063-9 · Cited by 89
Self-citationDitsch, N., Wöcke, A., Untch, M., Jackisch, C., Albert, U., Banys‐Paluchowski, M., Bauerfeind, I., Blohmer, J., Budach, W., Dall, P., et al. (2022) · Breast Care · doi:10.1159/000524879 · Cited by 89
Cardio-Oncology Education and Training
Alvarez-Cardona, J. A., Ray, J. C., Carver, J. R., Zaha, V. G., Cheng, R. K.-H., Yang, E. H., Mitchell, J. D., Stockerl-Goldstein, K. E., Kondapalli, L., Dent, S. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.079 · Cited by 87
Self-citationDexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Chow, E. J., Aggarwal, S. A., Doody, D. R., Aplenc, R., Armenian, S. H., Baker, K. S., Bhatia, S., Blythe, N. A., Colan, S. D., Constine, L. S., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02423 · Cited by 87
Self-citationCardiovascular Considerations Before Cancer Therapy
Raisi‐Estabragh, Z., Murphy, A. C., Ramalingam, S., Scherrer‐Crosbie, M., López‐Fernández, T., Reynolds, K. L., Aznar, M. C., Lin, A. E., Libby, P., Córdoba, R., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.017 · Cited by 93
Vasyuk, Y. A., Gendlin, G. E., Emelina, E. I., Shupenina, E. Y., Ballyuzek, M. F., Баринова, И. В., Vitsenya, M. V., Davydkin, I. L., Петрович, Д. Д., Duplyakov, D. V., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4703 · Cited by 95
Lopez‐Mattei, J., Yang, E. H., Baldassarre, L. A., Agha, A. M., Blankstein, R., Choi, A., Chen, M. Y., Meyersohn, N. M., Daly, R. P., Slim, A. M., et al. (2022) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2022.09.002 · Cited by 85
Self-citationLivi, L., Barletta, G., Martella, F., Saieva, C., Desideri, I., Bacci, C., Bene, M. R. D., Airoldi, M., AMOROSO, D., Coltelli, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3395 · Cited by 79
Dulf, P. L., Mocan, M., Coadǎ, C. A., Dulf, D. V., Moldovan, R., Bâldea, I., Fărcaș, A. D., Blendea, D. C., & Filip, G. A. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02382-z · Cited by 85
Stone, J., Perue, R. K., Abbasi, M. A., & Akhtari, M. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00924 · Cited by 78
Giuşcă, S., Korosoglou, G., Montenbruck, M., Geršak, B., Schwarz, A. K., Esch, S., Kelle, S., Wülfing, P., Dent, S. F., Lenihan, D. J., et al. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.012459 · Cited by 75
Self-citationYagi, R., Goto, S., Himeno, Y., Katsumata, Y., Hashimoto, M., MacRae, C. A., & Deo, R. C. (2024) · Nature Communications · doi:10.1038/s41467-024-45733-x · Cited by 81
Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer
Zaborowska-Szmit, M., Krzakowski, M. J., Kowalski, D. M., & Szmit, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051268 · Cited by 73
Heart Failure With Targeted Cancer Therapies
Hahn, V. S., Zhang, K. W., Sun, L., Narayan, V., Lenihan, D. J., & Ky, B. (2021) · Circulation Research · doi:10.1161/circresaha.121.318223 · Cited by 73
Self-citationGevaert, S., Halvorsen, S., Sinnaeve, P., Sambola, A., Gulati, G., Lancellotti, P., van der Meer, P., Lyon, A. R., Farmakis, D. T., Lee, G., et al. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab056 · Cited by 75
Self-citationMuhandiramge, J., Zalcberg, J. R., Londen, G. J. V., Warner, E. T., Carr, P. R., Haydon, A. M., & Orchard, S. G. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01309-w · Cited by 73
Cardiovascular Considerations After Cancer Therapy
Blaes, A. H., Nohria, A., Armenian, S. H., Bergom, C. R., Thavendiranathan, P., Barac, A., Sanchez‐Petitto, G., Desai, S., Zullig, L. L., Morgans, A. K., et al. (2025) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.06.006 · Cited by 85
Self-citationAssociation of Breast Cancer Irradiation With Cardiac Toxic Effects
Meattini, I., Poortmans, P. M., Aznar, M. C., Becherini, C., Bonzano, E., Cardinale, D. M., Lenihan, D. J., Marrazzo, L., Curigliano, G., & Livi, L. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7468 · Cited by 68
Self-citationClinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents
Rao, V. U., Reeves, D. J., Chugh, A. R., O’Quinn, R. P., Fradley, M. G., Raghavendra, M., Dent, S. F., Barac, A., & Lenihan, D. J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.009 · Cited by 66
Self-citationVo, J. B., Ramin, C. A., Veiga, L. H. S., Brandt, C., Curtis, R. E., Bodelón, C., Barac, A., Roger, V. L., Feigelson, H. S., Buist, D. S. M., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae107 · Cited by 71
Self-citationFradley, M. G., Nguyen, N., Madnick, D. L., Chen, Y., DeMichele, A. M., Makhlin, I., Dent, S. F., Lefebvre, B., Carver, J. R., Upshaw, J. N., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029361 · Cited by 61
Self-citationLin, M., Xiong, W., Wang, S., Li, Y., Hou, C., Li, C., & Li, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.821663 · Cited by 60
Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Picano, E., Ciampi, Q., Cortigiani, L., Arruda-Olson, A. M., Daros, C. B., Pretto, J. L. D. C. E. S., Cocchia, R., Bossone, E., Merli, E., Kane, G. C., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163641 · Cited by 60
Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis
Galimzhanov, A. M., Istanbuly, S., Tun, H. N., Özbay, B., Alasnag, M. A., Ky, B., Lyon, A. R., Kayıkçıoğlu, M., Tenekecioğlu, E., Panagioti, M., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad243 · Cited by 60
Self-citationCardiotoxic mechanisms of cancer immunotherapy – A systematic review
Lobenwein, D., Kocher, F., Dobner, S., Gollmann‐Tepeköylü, C., & Holfeld, J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.033 · Cited by 59
Antunes, P., Joaquim, A. V., Sampaio, F., Nunes, C., Ascensão, A. A. M. R., Vilela, E., Teixeira, M., Capela, A., Amarelo, A. L., Marques, C., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad063 · Cited by 56
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 109
Obasi, M., Abovich, A., Vo, J. B., Gao, Y., Papatheodorou, S., Nohria, A., Asnani, A. H., & Partridge, A. H. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01487-1 · Cited by 55
Bhatti, A. W., Patel, R. P., Dani, S. S., Khadke, S., Makwana, B., Lessey, C., Shah, J. R., Husami, Z., Yang, E. H., Thavendiranathan, P., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.08.001 · Cited by 55
Self-citationBouwer, N. I., Jager, A., Liesting, C., Kofflard, M. J. M., Brugts, J. J., Kitzen, J. J. E. M., Boersma, E. H., & Levin, M. (2020) · The Breast · doi:10.1016/j.breast.2020.04.005 · Cited by 59
Role of cardiovascular magnetic resonance imaging in cardio-oncology
Saunderson, C. E. D., Plein, S., & Manisty, C. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa345 · Cited by 55
Dent, S. F., Kikuchi, R., Kondapalli, L., Ismail-Khan, R. R., Brezden‐Masley, C., Barac, A., & Fradley, M. G. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_286019 · Cited by 59
Self-citationCardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Kourek, C., Touloupaki, M., Rempakos, A., Loritis, K., Tsougkos, E., PARASKEVAIDIS, I. A., & Briasoulis, Α. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080259 · Cited by 53
Management of Cardiac Toxicity Induced by Chemotherapy
Trapani, D., Zagami, P., Nicolò, E., Pravettoni, G., & Curigliano, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092885 · Cited by 57
Self-citationAdvances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
Xiao, H., Wang, X., Li, S., Liu, Y., Cui, Y., & Deng, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.753313 · Cited by 53
Murtagh, G., Januzzi, J. L., Scherrer‐Crosbie, M., Neilan, T. G., Dent, S. F., Ho, J. E., Appadurai, V., McDermott, R., & Akhter, N. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029574 · Cited by 58
Self-citationAtkins, K. M., Zhang, S. C., Kehayias, C. E., Guthier, C. V., He, J., Gasho, J. O., Bakhtiar, M., Silos, K. D., Kozono, D., Zei, P. C., et al. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.07.005 · Cited by 49
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
Dent, S. F., Morse, A. M., Burnette, S., Guha, A., & Moore, H. M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01114-x · Cited by 56
Self-citationCardiotoxicity of chemotherapy and targeted agents.
Mudd, T. W., Khalid, M., & Guddati, A. K. (2021) · PubMed Central · Cited by 48
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Vuong, J. T., Stein-Merlob, A. F., Cheng, R. K.-H., & Yang, E. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863314 · Cited by 48
The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus
Gent, D. G., & Dobson, R. (2023) · European Cardiology Review · doi:10.15420/ecr.2022.63 · Cited by 48
Hayek, S. S., Zaha, V. G., Bogle, C., Deswal, A. M., Langston, A. A., Rotz, S. J., Vasbinder, A. L., Yang, E. H., & Okwuosa, T. M. (2024) · Circulation · doi:10.1161/cir.0000000000001220 · Cited by 49
Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
Jiménez-Alejandre, R., Ruiz‐Fernández, I., & Martín, P. (2022) · Cancers · doi:10.3390/cancers14184494 · Cited by 50
Guha, A., Jain, P., Fradley, M. G., Lenihan, D. J., Gutierrez, J. M., Jain, C., Lima, M. J. G. D., Barnholtz‐Sloan, J. S., Oliveira, G. H., Dowlati, A., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3938 · Cited by 47
Self-citationOpportunities and Challenges in Cardio-Oncology: A Bibliometric Analysis From 2010 to 2022
Shi, S., Lv, J., Chai, R., Xue, W., Xu, X., Zhang, B., Li, Y., Wu, H., Song, Q., & Hu, Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101227 · Cited by 46
Tamura, Y., Tamura, Y., Takemura, R., Yamada, K., Taniguchi, H., Iwasawa, J., Yada, H., & Kawamura, A. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.10.007 · Cited by 48
Gao, Y., Wang, R., Jiang, J., Hu, Y., Li, H., & Wang, Y. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10328-z · Cited by 45
Cardiotoxicity of Fluoropyrimidines: Epidemiology, Mechanisms, Diagnosis, and Management
Jurczyk, M., Król, M., Midro, A., Kurnik‐Łucka, M., Poniatowski, A., & Gil, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194426 · Cited by 47
Chen, X., Lu, N., Huang, S., Zhang, Y., Liu, Z., & Wang, X. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110777 · Cited by 48
Mahto, R., Ahmed, S. U., Rahman, R. U., Aziz, R. M., Roy, P., Mallik, S., Li, A., & Shah, M. A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05605-5 · Cited by 49
Ng, H. S., Meng, X., Marin, T. S., Damarell, R., Buckley, E. S., Selvanayagam, J. B., & Koczwara, B. (2024) · Cancer Medicine · doi:10.1002/cam4.70057 · Cited by 43
Kamphuis, J. A. M., Linschoten, M., Cramer, M. J., Doevendans, P. A., Asselbergs, F. W., & Teske, A. J. (2020) · Cardio-Oncology · doi:10.1186/s40959-020-00079-3 · Cited by 43
Zaha, V. G., Hayek, S. S., Alexander, K. M., Beckie, T. M., Hundley, W. G., Kondapalli, L., Ky, B., Leger, K. F., Meijers, W. C., Moslehi, J. J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001032 · Cited by 44
Self-citation2020 Clinical practice guidelines for Myocarditis in adults
Arutyunov, G. P., Палеев, Ф. Н., Моисеева, О. М., Драгунов, Д. О., Sokolova, A. V., Arutyunov, A. G., Жиров, И. В., Blagova, O. V., Privalova, E. V., Габрусенко, С. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4790 · Cited by 48
Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
Liu, J., Lane, S., Lall, R., Russo, M., Farrell, L. A., Coskun, M. D., Curtin, C., Araujo‐Gutierrez, R., Scherrer‐Crosbie, M., Trachtenberg, B. H., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9245 · Cited by 42
Cardiotoxicity in breast cancer treatment: Causes and mitigation
Valiyaveettil, D., Joseph, D. M., & Malik, M. (2023) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2023.100760 · Cited by 55
Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity
Kumar, M., Thangavel, C., Becker, R. C., & Sadayappan, S. (2020) · Cancers · doi:10.3390/cancers13010086 · Cited by 46
Application of Gold Nanoparticle-Based Materials in Cancer Therapy and Diagnostics
Vodyashkin, A. A., Rizk, M. G. H., Kezimana, P., Kirichuk, A. A., & Stanishevskiy, Y. (2021) · ChemEngineering · doi:10.3390/chemengineering5040069 · Cited by 42
Tini, G., Cuomo, A., Battistoni, A., Sarocchi, M., Mercurio, V., Ameri, P., Volpe, M., Porto, I., Tocchetti, C. G., & Spallarossa, P. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.059 · Cited by 41
Nakagomi, Y., Tajiri, K., Shimada, S., Li, S., Inoue, K., Murakata, Y., Murata, M., Sakai, S., Sato, K., & Ieda, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884776 · Cited by 40
Lee, M., Chung, W., Lee, J., Park, C. S., Park, W. C., Song, B., & Youn, H. (2021) · Cancer Medicine · doi:10.1002/cam4.3956 · Cited by 40
Finke, D., Romann, S. W., Heckmann, M. B., Hund, H., Bougatf, N., Kantharajah, A., Katus, H. A., Müller, O. J., Frey, N., Giannitsis, E., et al. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13515 · Cited by 40
Metadata
- Authors
- Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., Patel, A., DeCara, J., Mitchell, J., Harrison, E., Moslehi, J., Witteles, R., Calabro, M. G., Orecchia, R., de Azambuja, E., Zamorano, J. L., Krone, R., Iakobishvili, Z., Carver, J., Armenian, S., Ky, B., Cardinale, D., Cipolla, C. M., Dent, S., & Jordan, K.
- Affiliations
- University of Milan (IT)
- Washington University Medical Center (US)
- University of South Florida (US)
- Lahey Hospital and Medical Center (US)
- Georgetown University (US)
- University of Minnesota (US)
- Mayo Clinic (US)
- University of Kansas Medical Center (US)
- Royal Brompton Hospital (GB)
- Centre Hospitalier Universitaire de Liège (BE)
- University of Chicago (US)
- Vanderbilt University (US)
- Stanford Medicine (US)
- European Institute of Oncology (IT)
- Hospital Universitario Ramón y Cajal (ES)
- Washington University in St. Louis (US)
- Tel Aviv University (IL)
- Hospital of the University of Pennsylvania (US)
- City Of Hope National Medical Center (US)
- University of Pennsylvania (US)
- Duke University (US)
- Heidelberg University (DE)
- ORCID
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 171-190
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC8019325
- OpenAlex
- W2999536665
- Cited by
- 1,031
- References
- 221
- Citations by year
- 2026: 108 · 2025: 152 · 2024: 168 · 2023: 189 · 2022: 188 · 2021: 143 · 2020: 83
- FWCI
- 93.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- HF
- Genentech
- Amgen
- Servier
- Pfizer
- Bristol-Myers Squibb
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- cardio-oncology, cardiotoxicity, cancer therapy, heart failure, cardiovascular screening, cardiovascular monitoring, novel cancer therapies, cardiovascular disease in cancer patients
- MeSH terms
- Antineoplastic Agents, Heart Diseases, Humans, Medical Oncology, Neoplasms, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
